EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Intranasal Seletracetam in a Patient with Reading Epilepsy: First‐in‐Human Use to Prevent Reflex Seizures

Matthias J Koepp iD, Kai-Nicolas Poppert, Thomas Felder iD, Aljoscha Thomschewski, Sandra Lafenthaler, Pavel Klein iD, Alexander Rotenberg iD, Wolfgang Löscher, Chris Rundfeldt, Eugen Trinka

Annals of Neurology · 2026

DOI: 10.1002/ana.78128 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Neurology, 2026. Verfasst von Matthias J Koepp und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, National Hospital for Neurology and Neurosurgery, Queens Square, London, UK. Hauptthemen laut MEDLINE: Epilepsy, Reflex, Anticonvulsants, Seizures. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report the first human use of intranasal seletracetam (SEL) to prevent reflex seizures. A patient with epilepsy with reading‐induced seizures on levetiracetam (3,000 mg/day) continued to experience reading‐induced focal seizures with preserved consciousness. Detectable in serum within 2 minutes of intranasal administration, 30 mg seletracetam delayed seizure onset from 1:56 (placebo) to 4:17 minutes post‐stimulus onset. A second 30 mg dose fully prevented seizures during 25 minutes of reading. Electroencephalogram (EEG) spike‐frequency declined dose‐dependently (3.1/min at placebo to 1.6/min after second dose), with reduced spike‐propagation on magnetoencephalography (MEG). Our findings support SEL as a promising non‐benzodiazepine acute seizure prevention and provide insight into reflex seizure dynamics. ANN NEUROL 2026;99:535–539

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsy, ReflexAnticonvulsantsSeizuresHumansAdministration, IntranasalElectroencephalographyMaleAdultMagnetoencephalographyFemaleReading

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Department of Neurology, National Hospital for Neurology and Neurosurgery, Queens Square, London, UK.
  • Department of Clinical and Experimental Epilepsy, UCL Queen Square Institute of Neurology, University College London, London, UK.
  • Department of Neurology, Neurocritical Care and Neurorehabilitation, Christian Doppler University Hospital, Centre of Cognitive Neuroscience, Paracelsus Medical University, Salzburg, Member of EpiCARE, Salzburg, Austria.
  • Department of Laboratory Medicine, Paracelsus Medical University, Salzburg, Austria.
  • Neuroscience Institute, Christian Doppler University Hospital, Centre of Cognitive Neuroscience, Paracelsus Medical University, Salzburg, Austria.
  • Mid-Atlantic Epilepsy and Sleep Center, Bethesda, MD, USA.

ORCID-Profile: Matthias J Koepp, Thomas Felder, Pavel Klein, Alexander Rotenberg

Zitieren

APA

Koepp, M. J., Poppert, K. N., Felder, T., Thomschewski, A., Lafenthaler, S., Klein, P., Rotenberg, A., Löscher, W., Rundfeldt, C., & Trinka, E. (2026). Intranasal Seletracetam in a Patient with Reading Epilepsy: First‐in‐Human Use to Prevent Reflex Seizures. Annals of Neurology. https://doi.org/10.1002/ana.78128

Vancouver

Koepp MJ, Poppert KN, Felder T, Thomschewski A, Lafenthaler S, Klein P, et al. Intranasal Seletracetam in a Patient with Reading Epilepsy: First‐in‐Human Use to Prevent Reflex Seizures. Annals of Neurology. 2026. doi:10.1002/ana.78128

BibTeX
@article{Koepp2026,
  author = {Koepp, Matthias J and Poppert, Kai-Nicolas and Felder, Thomas and Thomschewski, Aljoscha and Lafenthaler, Sandra and Klein, Pavel and Rotenberg, Alexander and Löscher, Wolfgang and Rundfeldt, Chris and Trinka, Eugen},
  title = {Intranasal Seletracetam in a Patient with Reading Epilepsy: First‐in‐Human Use to Prevent Reflex Seizures},
  journal = {Annals of Neurology},
  year = {2026},
  doi = {10.1002/ana.78128}
}
Kostenlos starten →